9 results on '"Nandakumar, Madhumitha"'
Search Results
2. N -methylation of a bactericidal compound as a resistance mechanism in Mycobacterium tuberculosis
- Author
-
Warrier, Thulasi, Kapilashrami, Kanishk, Argyrou, Argyrides, Ioerger, Thomas R., Little, David, Murphy, Kenan C., Nandakumar, Madhumitha, Park, Suna, Gold, Ben, Mi, Jianjie, Zhang, Tuo, Meiler, Eugenia, Rees, Mike, Somersan-Karakaya, Selin, Francisco, Esther Porras-De, Martinez-Hoyos, Maria, Burns-Huang, Kristin, Roberts, Julia, Ling, Yan, Rhee, Kyu Y., Mendoza-Losana, Alfonso, Luo, Minkui, and Nathan, Carl F.
- Published
- 2016
3. Control of biotin biosynthesis in mycobacteria by a pyruvate carboxylase dependent metabolic signal
- Author
-
Lazar, Nathaniel, Fay, Allison, Nandakumar, Madhumitha, Boyle, Kerry E., Xavier, Joao, Rhee, Kyu, and Glickman, Michael S.
- Published
- 2017
- Full Text
- View/download PDF
4. SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial.
- Author
-
McGovern, Barbara H, Ford, Christopher B, Henn, Matthew R, Pardi, Darrell S, Khanna, Sahil, Hohmann, Elizabeth L, O'Brien, Edward J, Desjardins, Christopher A, Bernardo, Patricia, Wortman, Jennifer R, Lombardo, Mary-Jane, Litcofsky, Kevin D, Winkler, Jonathan A, McChalicher, Christopher W J, Li, Sunny S, Tomlinson, Amelia D, Nandakumar, Madhumitha, Cook, David N, Pomerantz, Roger J, and Auninš, John G
- Subjects
CONFIDENCE intervals ,INVESTIGATIONAL drugs ,CLOSTRIDIUM diseases ,DISEASE relapse ,RANDOMIZED controlled trials ,HUMAN microbiota ,DESCRIPTIVE statistics ,GENOMICS ,POLYMERASE chain reaction ,FECAL microbiota transplantation ,SPORES ,PHARMACODYNAMICS - Abstract
Background Recurrent Clostridioides difficile infection (rCDI) is associated with loss of microbial diversity and microbe-derived secondary bile acids, which inhibit C. difficile germination and growth. SER-109, an investigational microbiome drug of donor-derived, purified spores, reduced recurrence in a dose-ranging, phase (P) 1 study in subjects with multiple rCDIs. Methods In a P2 double-blind trial, subjects with clinical resolution on standard-of-care antibiotics were stratified by age (< or ≥65 years) and randomized 2:1 to single-dose SER-109 or placebo. Subjects were diagnosed at study entry by PCR or toxin testing. Safety, C. difficile–positive diarrhea through week 8, SER-109 engraftment, and bile acid changes were assessed. Results 89 subjects enrolled (67% female; 80.9% diagnosed by PCR). rCDI rates were lower in the SER-109 arm than placebo (44.1% vs 53.3%) but did not meet statistical significance. In a preplanned analysis, rates were reduced among subjects ≥65 years (45.2% vs 80%, respectively; RR, 1.77; 95% CI, 1.11–2.81), while the <65 group showed no benefit. Early engraftment of SER-109 was associated with nonrecurrence (P <.05) and increased secondary bile acid concentrations (P <.0001). Whole-metagenomic sequencing from this study and the P1 study revealed previously unappreciated dose-dependent engraftment kinetics and confirmed an association between early engraftment and nonrecurrence. Engraftment kinetics suggest that P2 dosing was suboptimal. Adverse events were generally mild to moderate in severity. Conclusions Early SER-109 engraftment was associated with reduced CDI recurrence and favorable safety was observed. A higher dose of SER-109 and requirements for toxin testing were implemented in the current P3 trial. Clinical Trials Registration NCT02437487, https://clinicaltrials.gov/ct2/show/NCT02437487?term=SER-109&draw= 2&rank=4. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
5. Impact of CodY protein on metabolism, sporulation and virulence in Clostridioides difficile ribotype 027.
- Author
-
Daou, Nadine, Wang, Yuanguo, Levdikov, Vladimir M., Nandakumar, Madhumitha, Livny, Jonathan, Bouillaut, Laurent, Blagova, Elena, Zhang, Keshan, Belitsky, Boris R., Rhee, Kyu, Wilkinson, Anthony J., Sun, Xingmin, and Sonenshein, Abraham L.
- Subjects
TOXIN synthesis ,BACTERIAL spores ,TOXINS ,ANTIBIOTICS ,BACTERIAL sporulation ,LABORATORY mice - Abstract
Toxin synthesis and endospore formation are two of the most critical factors that determine the outcome of infection by Clostridioides difficile. The two major toxins, TcdA and TcdB, are the principal factors causing damage to the host. Spores are the infectious form of C. difficile, permit survival of the bacterium during antibiotic treatment and are the predominant cell form that leads to recurrent infection. Toxin production and sporulation have their own specific mechanisms of regulation, but they share negative regulation by the global regulatory protein CodY. Determining the extent of such regulation and its detailed mechanism is important for understanding the linkage between two apparently independent biological phenomena and raises the possibility of creating new ways of limiting infection. The work described here shows that a codY null mutant of a hypervirulent (ribotype 027) strain is even more virulent than its parent in a mouse model of infection and that the mutant expresses most sporulation genes prematurely during exponential growth phase. Moreover, examining the expression patterns of mutants producing CodY proteins with different levels of residual activity revealed that expression of the toxin genes is dependent on total CodY inactivation, whereas most sporulation genes are turned on when CodY activity is only partially diminished. These results suggest that, in wild-type cells undergoing nutrient limitation, sporulation genes can be turned on before the toxin genes. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
6. Targeting protein biotinylation enhances tuberculosis chemotherapy.
- Author
-
Tiwari, Divya, Park, Sae Woong, Essawy, Maram M., Dawadi, Surendra, Mason, Alan, Nandakumar, Madhumitha, Zimmerman, Matthew, Mina, Marizel, Ho, Hsin Pin, Engelhart, Curtis A., Ioerger, Thomas, Sacchettini, James C., Rhee, Kyu, Ehrt, Sabine, Aldrich, Courtney C., Dartois, Véronique, and Schnappingesr, Dirk
- Subjects
BIOTIN ,CHEMICAL inhibitors ,LIGASES ,MYCOBACTERIUM tuberculosis ,LABORATORY mice - Abstract
Inhibitors of biotin protein ligase and protein biotinylation in Mycobacterium tuberculosis act synergistically with the drug rifampicin, potentially shortening tuberculosis treatment. A new drug target for combatting TB: Mycobacterium tuberculosis (Mtb) is the causative agent of tuberculosis (TB). The paucity of validated drug targets limits efforts to develop new drugs to combat TB. New work by Tiwari et al. establishes bacterial biotin protein ligase (BPL), the enzyme Mtb requires to covalently attach the essential vitamin biotin to biotin-dependent enzymes, as an alternative frontline target in the development of drugs against TB. These investigators demonstrated that inactivation of BPL killed Mtb in vitro and eradicated this pathogen from infected mice. Inhibition of protein biotinylation increased the potency of the frontline TB drug rifampicin both in vitro and during infection of mice. Successful drug treatment for tuberculosis (TB) depends on the unique contributions of its component drugs. Drug resistance poses a threat to the efficacy of individual drugs and the regimens to which they contribute. Biologically and chemically validated targets capable of replacing individual components of current TB chemotherapy are a major unmet need in TB drug development. We demonstrate that chemical inhibition of the bacterial biotin protein ligase (BPL) with the inhibitor Bio-AMS (5′-[N-(d-biotinoyl)sulfamoyl]amino-5′-deoxyadenosine) killed Mycobacterium tuberculosis (Mtb), the bacterial pathogen causing TB. We also show that genetic silencing of BPL eliminated the pathogen efficiently from mice during acute and chronic infection with Mtb. Partial chemical inactivation of BPL increased the potency of two first-line drugs, rifampicin and ethambutol, and genetic interference with protein biotinylation accelerated clearance of Mtb from mouse lungs and spleens by rifampicin. These studies validate BPL as a potential drug target that could serve as an alternate frontline target in the development of new drugs against Mtb. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
7. Gamma-Linolenic and Stearidonic Acids Are Required for Basal Immunity in Caenorhabditis elegans through Their Effects on p38 MAP Kinase Activity.
- Author
-
Nandakumar, Madhumitha and Man-Wah Tan
- Subjects
- *
PHYSIOLOGICAL effects of unsaturated fatty acids , *CAENORHABDITIS elegans , *IMMUNE response , *IMMUNITY , *PSEUDOMONAS aeruginosa , *ARACHIDONIC acid , *DISEASE susceptibility , *BACTERIAL diseases - Abstract
Polyunsaturated fatty acids (PUFAs) form a class of essential micronutrients that play a vital role in development, cardiovascular health, and immunity. The influence of lipids on the immune response is both complex and diverse, with multiple studies pointing to the beneficial effects of long-chain fatty acids in immunity. However, the mechanisms through which PUFAs modulate innate immunity and the effects of PUFA deficiencies on innate immune functions remain to be clarified. Using the Caenorhabditis elegans-Pseudomonas aeruginosa host-pathogen system, we present genetic evidence that a D6-desaturase FAT-3, through its two 18-carbon products-gamma-linolenic acid (GLA, 18:3n6) and stearidonic acid (SDA, 18:4n3), but not the 20-carbon PUFAs arachidonic acid (AA, 20:4n6) and eicosapentaenoic acid (EPA, 20:5n3)-is required for basal innate immunity in vivo. Deficiencies in GLA and SDA result in increased susceptibility to bacterial infection, which is associated with reduced basal expression of a number of immune-specific genes-including spp-1, lys-7, and lys-2-that encode antimicrobial peptides. GLA and SDA are required to maintain basal activity of the p38 MAP kinase pathway, which plays important roles in protecting metazoan animals from infections and oxidative stress. Transcriptional and functional analyses of fat-3-regulated genes revealed that fat-3 is required in the intestine to regulate the expression of infection- and stress-response genes, and that distinct sets of genes are specifically required for immune function and oxidative stress response. Our study thus uncovers a mechanism by which these 18-carbon PUFAs affect basal innate immune function and, consequently, the ability of an organism to defend itself against bacterial infections. The conservation of p38 MAP kinase signaling in both stress and immune responses further encourages exploring the function of GLA and SDA in humans. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
8. Metabolomic Profiling of Portal Blood and Bile Reveals Metabolic Signatures of Primary Sclerosing Cholangitis.
- Author
-
Tietz-Bogert, Pamela S., Kim, Minsuk, Cheung, Angela, Tabibian, James H., Heimbach, Julie K., Rosen, Charles B., Nandakumar, Madhumitha, Lazaridis, Konstantinos N., LaRusso, Nicholas F., Sung, Jaeyun, and O'Hara, Steven P.
- Subjects
METABOLOMICS ,CHOLANGITIS ,BILE duct diseases ,DRUG therapy ,PATHOLOGICAL physiology - Abstract
Primary sclerosing cholangitis (PSC) is a pathogenically complex, chronic, fibroinflammatory disorder of the bile ducts without known etiology or effective pharmacotherapy. Emerging in vitro and in vivo evidence support fundamental pathophysiologic mechanisms in PSC centered on enterohepatic circulation. To date, no studies have specifically interrogated the chemical footprint of enterohepatic circulation in PSC. Herein, we evaluated the metabolome and lipidome of portal venous blood and bile obtained at the time of liver transplantation in patients with PSC (n = 7) as compared to individuals with noncholestatic, end-stage liver disease (viral, metabolic, etc. (disease control, DC, n = 19)) and to nondisease controls (NC, living donors, n = 12). Global metabolomic and lipidomic profiling was performed on serum derived from portal venous blood (portal serum) and bile using ultraperformance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) and differential mobility spectroscopy-mass spectroscopy (DMS-MS; complex lipid platform). The Mann–Whitney U test was used to identify metabolites that significantly differed between groups. Principal-component analysis (PCA) showed significant separation of both PSC and DC from NC for both portal serum and bile. Metabolite set enrichment analysis of portal serum and bile demonstrated that the liver-disease cohorts (PSC and DC) exhibited similar enrichment in several metabolite categories compared to NC. Interestingly, the bile in PSC was uniquely enriched for dipeptide and polyamine metabolites. Finally, analysis of patient-matched portal serum and biliary metabolome revealed that these biological fluids were more homogeneous in PSC than in DC or NC, suggesting aberrant bile formation and enterohepatic circulation. In summary, PSC and DC patients exhibited alterations in several metabolites in portal serum and bile, while PSC patients exhibited a unique bile metabolome. These specific alterations in PSC are amenable to hypothesis testing and, potentially, therapeutic pharmacologic manipulation. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
9. Isocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis.
- Author
-
Nandakumar, Madhumitha, Nathan, Carl, and Rhee, Kyu Y.
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.